Sr. Director, Global Franchise Head Gastroenterology

h3Sr. Director, Global Franchise Head Gastroenterology Rare Disease /h3 /brpAlfasigma is a privately held global healthcare company founded over 75 years ago in Italy, where it remains headquartered today in Bologna and Milan. The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa. /p /brpOver three years ago, we embarked on a transformative journey to become ba truly global innovative healthcare company with a leading focus on Gastrointestinal (GI) health /b. We have experienced remarkable growth, nearly doubled our revenues, expanding geographically, and integrating several key acquisitions. We have also evolved our portfolio, expanded into rare and specialty segments, and strengthened our pipeline and people's capabilities. /p /brpbBut our journey is far from complete /b In fact, this is just the beginning of a bold new chapter in Alfasigma's history. We are committed to advancing innovation and leveraging our deep expertise to provide better health and a better quality of life for patients and consumers worldwide and expand our reach across diverse markets. /p /brh3Scope of the Role /h3 /brpThe Global Franchise Head Gastroenterology Rare Disease is responsible for defining and executing the global Gastroenterology Rare Disease Therapeutic Area Strategy to maximize long-term franchise value and patient impact. This role leads the development of global brand strategies, ensures excellence in brand planning and execution, drives resource allocation decisions, and partners closely with Research Development, Medical Affairs, and key commercial functions to build a sustainable and differentiated Gastroenterology Rare Disease franchise. /p /brpThe role has full accountability for delivering the franchise growth ambition through effective portfolio prioritization, strategic investment decisions, and leadership of the Global Gastroenterology Rare Disease Marketing Team. /p /brh3Your Role /h3 /brul /brli /brp1. Therapeutic Area Strategy Franchise Leadership /p /brpDefine and co-lead the long-term Gastroenterology Rare Disease Therapeutic Area Strategy with RD, leveraging key stakeholders across Medical Affairs, Business Development, Market Access, and Commercial functions. /p /brpTranslate scientific, competitive, and market insights into a clear "where to play" and "how to win" franchise strategy. /p /brpEnsure alignment between pipeline development, lifecycle management opportunities, licensing opportunities, and commercial priorities. /p /brpDrive cross-functional decision-making to maximize the value of current and future Gastroenterology Rare Disease assets. /p /brpEstablish a sustainable franchise vision that extends beyond individual brands, indications, and disease areas. /p /br /li /brli /brp2. Brand Strategy Execution Excellence /p /brpEnsure the development and implementation of best-in-class global brand plans across all Gastroenterology Rare Disease assets. /p /brpEstablish clear brand ambition, positioning, value propositions, and strategic priorities. /p /brpMonitor execution of global brand plans and ensure strong alignment between global strategy and local implementation. /p /brpDefine relevant KPIs and performance metrics to track strategic progress and execution quality. /p /brpDrive continuous improvement in commercial effectiveness and launch excellence. /p /br /li /brli /brp3. Commercial Ambition Resource Allocation /p /brpDefine the 3-year franchise ambition, including sales, market share, and profitability objectives. /p /brpDevelop robust business cases and investment scenarios to support growth objectives. /p /brpLead franchise budgeting and investment prioritization processes. /p /brpAllocate resources across products, indications, markets, and strategic initiatives to maximize return on investment. /p /brpEnsure the appropriate balance between short-term performance delivery and long-term franchise value creation. /p /brpIdentify and prioritize growth opportunities across the Gastroenterology Rare Disease portfolio. /p /brpLead lifecycle management strategies to optimize value throughout the product lifecycle. /p /brpEvaluate new indication opportunities, evidence-generation priorities, and franchise expansion initiatives. /p /brpPartner with Business Development and RD teams to assess and maximize external innovation opportunities relevant to the Gastroenterology Rare Disease strategy. /p /brpLead, coach, and develop a high-performing team of Global Brand Managers. /p /brpFoster a culture of accountability, collaboration, innovation, and execution excellence. /p /brpBuild strong cross-functional partnerships across Global and Local organizations. /p /brpEnsure effective talent development, succession planning, and capability building within the franchise team. /p /brpInspire and align stakeholders around a shared franchise vision and strategic priorities. /p /br /li /br /ul /brh3Who Are You /h3 /brul /brliSignificant internatio